Heart Failure clinical trials in Texas
84 active Heart Failure trials with a site in Texas. Describe your situation to see which ones look like a fit.
- Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Home-based Cardiac Rehabilitation in Heart Failure
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
- Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
- Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
- A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
- Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure
- Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- A Study of LY3971297 in Participants With Heart Failure
- A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Assessment of CCM in HF With Higher Ejection Fraction
- A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
- Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
- Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
- A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)
- Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
- A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- The ROle of Compression StocKings in Heart Failure Patients
- Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- Left vs Left Randomized Clinical Trial
- IEEM-Heat and Heart Failure
- Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
- Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
- NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
- Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
- 18F-mFBG Imaging for Myocardial Sympathetic Innervation
- PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Alleviant ALLAY-HF Study
- Alleviant ALLAY-HFrEF Study
- CCM OPEN HF Registry
- OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.